Comparison of LMA-Fastrach and I-gel for Blind Tracheal Intubation.
1 other identifier
interventional
160
1 country
1
Brief Summary
The investigators aim to compare two different types of supraglottic devices for tracheal intubation in patients undergoing elective surgery under general anesthesia. Our hypothesis is that the use of the I-gel supraglottic airway will result in a higher first attempt success rate of blind tracheal intubation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2009
CompletedFirst Posted
Study publicly available on registry
November 4, 2009
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedAugust 3, 2017
August 1, 2017
2 months
November 3, 2009
August 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
First attempt success rate of tracheal intubation.
After successful insertion of tracheal tube
Secondary Outcomes (4)
Time needed for successful insertion of a supraglottic device.
After insertion
First and total attempt success rate of supraglottic device insertion.
After insertion
Total time and number of attempts needed to obtain successful tracheal intubation.
After tracheal intubation
Fiberoptic view following the supraglottic device insertion.
After insertion of the device
Study Arms (2)
LMA-Fastrach
ACTIVE COMPARATOR* Induction of general anesthesia with 1,5-2,5 mg/kg propofol and 1-3 mcg/kg fentanyl and neuromuscular relaxation with 0,6 mg/kg of rocuronium. * Direct laryngoscopy, evaluation of laryngeal view grade according to Cormack-Lehane classification * Insertion of LMA-Fastrach (sizes 3,4 or 5), establishment of ventilation * Evaluation of glottic view through LMA-Fastrach using fibrescope (one out of ten patients) * Tracheal intubation through the LMA-Fastrach * With the endotracheal tube in place, the anaesthesiologist will proceed to the removal of supraglottic device
I-gel
ACTIVE COMPARATOR* Induction of general anesthesia with 1,5-2,5 mg/kg propofol and 1-3 mcg/kg fentanyl and neuromuscular relaxation with 0,6 mg/kg of rocuronium. * Direct laryngoscopy, evaluation of laryngeal view grade according to Cormack-Lehane classification * Insertion of I-gel (sizes 3,4 or 5), establishment of ventilation * Evaluation of glottic view through I-gel using fibrescope (one out of ten patients) * Tracheal intubation through the I-gel * With the endotracheal tube in place, the anaesthesiologist will proceed to the removal of supraglottic device
Interventions
Tracheal intubation through a supraglottic airway device(LMA-Fastrach).
Eligibility Criteria
You may qualify if:
- Age 18 and older
- ASA physical status 1-3
- Patients undergoing elective surgery under general anesthesia, requiring endotracheal intubation
You may not qualify if:
- ASA physical status 4-5
- Contraindications to muscle relaxation
- Anticipated or known difficult intubation or ventilation
- Patients with limited mouth opening (less than 2 cm)
- Patients at increased risk of aspiration, or having an history of symptomatic gastroesophageal reflux or hiatal hernia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de l'Université de Montréal-Hôpital Notre-Dame
Montreal, Quebec, H2L 4M1, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathalie Massicotte, MD, FRCPC
Centre hospitalier de l'Université de Montréal (CHUM)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2009
First Posted
November 4, 2009
Study Start
March 1, 2010
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
August 3, 2017
Record last verified: 2017-08